Epicatechin administration leads to necrotic cell death of rat leukaemia promyelocytes in vivo

In Vivo

Volumn 25, Issue 1, 2011, Pages 29-34

  Papiez, Monika A ^a   Baran, Jarosław ^b   Bukowska Straková, Karolina ^b   Krośniak, Mirosław ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

( ) Epicatechin; Acute myeloid leukaemia; DNA damage; Necrosis; Rat

Indexed keywords

EPICATECHIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW CELL; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA DETERMINATION; DNA STRAND; DRUG MECHANISM; FLOW CYTOMETRY; GENOTOXICITY; LEUKEMIA CELL; MALE; NECROSIS; NONHUMAN; RAT;

EID: 79952022949     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Sadzuka Y, Sugiyama T and Hiroto S: Modulation of cancer chemotherapy by green tea. Clin Cancer Res 4: 153-156, 1998. (Pubitemid 28062889)
2. Bertolini F, Fusetti L, Cinieri S, Martinielii G and Pruneri G: Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma. Leukemia 14: 1477-1482, 2000. (Pubitemid 30601356)
3. Kuo YC, Yu CL, Liu CY, Wang SF, Pan PC, Wu MT, Ho CK, Lo YS, Li Y and Christiani DC: A population-based, case-control study of green tea consumption and leukemia risk in southwestern Taiwan. Cancer Cause Control 20: 57-65, 2009.
4. Pastore RL and Fratellone P: Potential health benefits of green tea (Camellia sinensis): a narrative review. Diet Nutrition 2: 531-539, 2006.
5. Lea MA, Xiao Q, Sandhukhan AK, Cottle S, Wang ZY and Yang CS: Inhibitory effects of tea extracts and (-)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells. Cancer Lett 68: 231-236, 1993. (Pubitemid 23090683)
6. Shammas MA, Neri P, Koley H, Batchu RB, Bertheau RC, Munshi V, Prabhala R, Fulciniti MF, Tai YT, Treon SP, Goyal RK, Anderson KC and Munshi NC: Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications. Blood 108: 2804-2810, 2006.
7. Hadi SM, Asad SF, Singh S and Ahmad A: Putative mechanism for anticancer and apoptosis inducing properties of plant-derived polyphenolic compounds. IUBMB Life 50: 167-171, 2000. (Pubitemid 32037930)
8. Yamamoto T, Hsu S, Lewis J, Wataha J, Dickinson D, Singh B, Bollag WB, Lockwood P, Ueta E, Osaki T and Schuster G: Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells. J Pharmacol Exp Ther 307: 230-236, 2003. (Pubitemid 37151912)
9. Azam S, Hadi N, Khan NU and Hadi SM: Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties. Toxicol In Vitro 18: 555-561, 2004. (Pubitemid 38900862)
10. Nakazato T, Sagawa M, Yamato K, Xian M, Yamamoto T, Suematsu M, Ikeda Y and Kizaki M: Myeloperoxidase is a key regulator of oxidative stress-mediated apoptosis in myeloid leukemia cells. Clin Cancer Res 13: 5436-5445, 2007. (Pubitemid 47510371)
11. Feng R, Ni HM, Wang SY, Tourkova IL, Shurin MR and Harada H: Cyanidin-3-rutinoside, a natural polyphenol antioxidant, selectively kills leukemic cells by induction of oxidative stress. J Biol Chem 282: 13468-13476, 2007. (Pubitemid 47100551)
12. Nakazato T, Ito K, Miyakawa Y, Kinjo K, Yamada T, Hozumi N, Ikeda Y and Kizaki M: Catechin, a green tea component, rapidly induces apoptosis of myeloid leukemia cells via modulation of reactive oxygen species production in vitro and inhibits tumor growth in vivo. Hematol J 90: 317-325, 2005. (Pubitemid 40388981)
13. Granado-Serrano AB, Martin MA, Izquierdo-Pulido M, Goya L, Bravo L and Ramos S: Molecular mechanisms of (-)-epicatechin and chlorogenic acid on the regulation of the apoptotic and survival/proliferation pathway in a human hepatoma cell line. J Agric Chem 55: 2020-2027, 2007. (Pubitemid 46479616)
14. Noe V, Penuelas S, Lamuela-Raventos RM, Permanyer J, Ciudad CJ and Izquierdo-Pulido M: Epicatechin and a cocoa polyphenolic extract modulate gene expression in human Caco-2 cells. J Nutr 134: 2509-2516, 2004. (Pubitemid 39315247)
15. Spalteholz H, Furtmuller PG, Jakopitsch Ch, Obinger Ch, Schewe T, Sies H and Arnhold J: Kinetic evidence for rapid oxidation of (-)-epicatechin by human myelopeoxidase. Biochem Biophys Res Commun 371: 810-813, 2008.
16. Oikawa S, Furukawa A, Asada H, Hirakawa K and Kawanish S: Catechins induce oxidative damage to cellular and isolated DNA through the generation of reactive oxygen species. Free Radic Res 37: 881-890, 2003. (Pubitemid 36939604)
17. Van Bekkum DW and Hagenbeek A: Relevance of the BN leukemia as a model for human acute myeloid leukemia. Blood Cell 3: 565-579, 1977. (Pubitemid 8259621)
18. Hubeek I, Comijn EM, Van Der Wilt CL, Merriman RL, Padron JM, Kaspers GJL and Peters GJ: CI-994 (N-acetyl-dinaline) in combination with conventional anti-cancer agents is effective against acute myeloid leukemia in vitro and in vivo. Oncol Rep 19: 1517-1523, 2008.
19. Martens ACM, Van Bekkum DW and Hagenbeek A: The BN acute myelocytic leukemia (BNML) (a rat model for studying human acute myelocytic leukemia (AML)). Leukemia 4: 241-257, 1990.
20. Papiez MA, Cierniak A, Krzyściak W, Bzowska M, Taha HM, Józkowicz A and Piskuła M: The changes of antioxidant defense system caused by quercetin administration do not lead to DNA damage and apoptosis in the spleen and bone marrow cells of rats. Food Chem Toxicol 46: 3053-3058, 2008.
21. Martens ACM, Johnson RJ, Kaizer H and Hagenbeek A: Characteristics of a monoclonal antibody (RM124) against acute myelocytic leukemia cells. Exp Hematol 12: 667-671, 1984.
22. Papiez MA, Dybała M, Sowa-Kućma M, Krzyściak W, Taha H, Józkowicz A and Nowak G: Evaluation of oxidative status and depression-like responses in Brown Norway rats with acute myeloid leukemia. Prog Neuropsychopharmacol Biol Psychiatry 33: 596-604, 2009.
23. Cerutti PA: Prooxidant status and tumor promotion. Science 227: 375-381, 1985.
24. Schumacker PT: Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10: 175-176, 2006.
25. Delgado ME, Haza AI, Garcia A and Morales P: Dietary polyphenols protect against N-nitrosamines and benzo(a)pyrene-induced DNA damage (strand breaks and oxidized purines/pyrimidines) in HepG2 human hepatoma cells. Eur J Nutr 47: 479-490, 2008.
26. Spencer JP, Schroeter H, Kuhnle G, Srai SKS, Tyrrell RM, Hahn U and Rice-Evans C: Epicatechin and its in vivo metabolite, 3′-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. Biochem J 354: 493-500, 2001.
27. Matsuo T, Kuriyama K and Miyazaki Y: The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype. Leukemia 17: 1538-1543, 2003. (Pubitemid 36986955)
28. Loeb LA: A mutator phenotype in cancer. Cancer Res 61: 3230-3239, 2001.
29. Loeb LA, Bielas JH and Beckman RA: Cancers exhibit a mutator phenotype: clinical implications. Cancer Res 68: 3551-3557, 2008.
30. Sallmyr A, Fan J and Rassool FV: Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double-strand breaks (DSBs) and error-prone repair. Cancer Lett 270: 1-9, 2008.
31. Nowicki M, Koptyra FRM, Slupianek A, Stklosa T, Gloc E, Nieborowska-Skorska M Blasiak J and Skorski T: BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood 104: 3746-3753, 2004. (Pubitemid 39564453)
32. Rassool FV, Gaymes TJ, Omidvar N, Brady N, Lea NC and Pla M: Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia. Cancer Res 67: 8762-8771, 2007.
33. Karanjawala ZE, Murphy N, Hinton DR, Hsieh CL and Lieber MR: Oxygen metabolism causes chromosome breaks and is associated with the neuronal apoptosis observed in DNA double-strand break repair mutants. Curr Biol 12: 397-402, 2002. (Pubitemid 34209287)
34. Roos WP and Kaina B: DNA damage-induced cell death by apoptosis. Trends Mol Med 12: 440-450, 2006. (Pubitemid 44291571)
35. Iwasaki R, Ito K, Ishida T, Hamanoue M, Adachi S, Watanabe T and Sato Y: Catechin, green tea component, causes caspase-independent necrosis-like death in chronic myelogenous leukemia. Cancer Sci 100: 349-356, 2009.
36. Reiter I, Krammer B and Schwamberger G: Cutting edge: differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities. J Immunol 163: 1730-1732, 1999.
37. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S and Bhardwaj N: Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 191: 423-434, 2000.